Lomustine is used to treat certain types of brain tumors. It is a highly lipid-soluble drug, thus it crosses the blood-brain barrier. It has also been used in veterinary practice as a treatment for mast cell tumors in dogs. Reference standards of Lomustine API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Lomustine
Catalogue No.:PA 12 51000
CAS :
Molecular Formula : C9H16ClN3O2
Molecular Weight : 233.70
1-(2-Chloroethyl)-3-cyclohexylurea
Catalogue No.:PA 12 51020
Molecular Formula : C9H17ClN2O
Molecular Weight : 204.70
1,3-dicyclohexylurea
Catalogue No.:PA 12 51030
Molecular Formula : C13H24N2O
Molecular Weight : 224.34
3-(2-Chloroethyl)-1-cyclohexyl-1-nitrosourea
Catalogue No.:PA 12 51510
Molecular Weight : 233.7
Cyclohexanone-d6
Catalogue No.:PA STI 023360
Molecular Formula : C6H4D6O
Molecular Weight : 104.18
Cyclohexanone-13C6
Catalogue No.:PA STI 023370
Molecular Formula : 13C6H10O
Molecular Weight : 104.09
N-Denitroso-N'-nitroso Lomustine-d4
Catalogue No.:PA STI 025880
Molecular Formula : C9H12D4ClN3O2
Molecular Weight : 237.72
Lomustine (L0745000)
Catalogue No.:PA EPL0745000
Molecular Formula : NA
Molecular Weight : NA
Lomustine (1369419)
Catalogue No.:PA USP1369419
Lomustine Related Compound B (1-(2-Chloroethyl)-3-cyclohexylurea) (1369431)
Catalogue No.:PA USP1369431
Lomustine Related Compound C (1,3-Dicyclohexylurea) (1369442)
Catalogue No.:PA USP1369442
Lomustine Related Compound D (3-(2-Chloroethyl)-1-cyclohexyl-1-nitrosourea) (1369453)
Catalogue No.:PA USP1369453
cis-4-Hydroxy-lomustine
Catalogue No.:PA 12 0511000
Molecular Formula : C9H16ClN3O3
Molecular Weight : 249.7
trans-4-Hydroxy-lomustine
Catalogue No.:PA 12 0511001
3-(2-Chloroethyl)-1,1-dicyclohexylurea
Catalogue No.:PA 12 0511002
Molecular Formula : C15H27ClN2O
Molecular Weight : 286.84
1-(2-Chloroethyl)-3,3-dicyclohexyl-1-nitrosourea
Catalogue No.:PA 12 0511003
Molecular Formula : C15H26ClN3O2
Molecular Weight : 315.84
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
